Key Takeaways NDSN's Medical and Fluid Solutions organic sales rose 7.4% year over year in Q4 fiscal 2025.Nordson improved segment EBITDA margins through higher sales, footprint optimization and cost reductions.The Atrion acquisition expanded Nordson's medical offerings in infusion and cardiovascular therapies.Nordson Corporation (NDSN) is witnessing solid momentum in the Medical and Fluid Solutions segment, organic sales from which increased 7.4% year over year in the fourth quarter of fiscal 2025 (ended O ...